Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
USRE47826 | INNOCOLL PHARMS | Drug delivery device for providing local analgesia, local anesthesia or nerve blockage |
May, 2029
(6 years from now) |
Exclusivity | Exclusivity Expiration |
---|---|
New Product (NP) | Aug 28, 2023 |
Market Authorisation Date: 28 August, 2020
Treatment: A method for inducing a post-surgical analgesia sparing effect by implanting at the surgical site a collagen sponge containing bupivacaine hcl which provides local anesthesia for up to 24 hours follow...
Dosage: IMPLANT;IMPLANTATION
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic